Vysera is pleased to announce a three-part agreement with Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures. The transactions provide Merit with an exclusive license for certain valve technology that may be incorporated into non-vascular stents, specifically esophageal stents, to address acid reflux conditions. Secondly, the transactions provide Merit with an exclusive license for the development and use of certain biomaterial technology for the coating of selected non-vascular stents and gastrointestinal and drainage catheters.
Finally, Merit has made an equity investment for a minority interest in Vysera, and Fred P. Lampropoulos, Merit’s Chairman, President and Chief Executive Officer, has been elected as a director of Vysera. Full details of the deal can be found here;
Vysera is pleased to announce we are currently recruiting for five positions with the company. Having just completed the first regulatory submission, the company has additional products in the product pipeline which it now intends to persue. Candidates who are suited to work in a fast paced, young innovative company and have the drive, experience and skills to take on new challenges individually and as part of a team, please feel free to contact us about the following positions